Login to Your Account

Themis Plans Trials for Dengue And Chikungunya Vaccines

By Cormac Sheridan
Staff Writer

Friday, March 29, 2013
Themis Bioscience GmbH is planning to begin clinical trials of viral vaccine candidates to protect against Dengue virus and Chikungunya virus infections before year-end, following successful preclinical proof of concept studies.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription